Kendra Louise Nelson

This inventor holds 5 USPTO granted patents and 9 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Pfizer Corporation, Pfizer Products Inc., Other. Active years: 2010-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kendra Louise Nelson. Retrieved from https://idiyas.com/inventor/kendra-louise-nelson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 (Patent Applications = 9)

% Patents Active = 80.0

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 61(Granted Patents)

Location History:

New London, CT (US) (2010)
Mystic, CT (US) (2011 - 2019)

Company Filing History:

1 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2010-2019

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10450297 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2019-10-22),

2. 8440822 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2013-05-14),

3. 8247411 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2012-08-21),

4. 7928109 - Sulfonyl amide derivatives for the treatment of abnormal cell growth (2011-04-19),

5. 7820648 - Pyrimidine derivatives for the treatment of abnormal cell growth (2010-10-26),

Title: Kendra Louise Nelson: Innovator in Pharmaceutical Chemistry

Introduction

Kendra Louise Nelson is a prominent inventor based in Mystic, CT (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of abnormal cell growth.

Latest Patents

Kendra holds a total of 5 patents, with her latest inventions focusing on sulfonyl amide derivatives. These compounds are designed for the treatment of abnormal cell growth, including cancer, in mammals. The inventions detail a method of using these compounds in therapeutic applications, especially for humans, and include pharmaceutical compositions that incorporate these novel derivatives.

Career Highlights

Throughout her career, Kendra has worked with notable organizations, including Pfizer Corporation. Her work has been instrumental in advancing the understanding and treatment of various medical conditions through innovative chemical solutions.

Collaborations

Kendra has collaborated with esteemed colleagues such as Michael Luzzio and Samit Kumar Bhattacharya, contributing to a dynamic exchange of ideas and expertise in her field.

Conclusion

Kendra Louise Nelson's work exemplifies the impact of innovation in pharmaceutical chemistry, particularly in the fight against cancer. Her contributions continue to inspire advancements in medical treatments and research.

Profile summary based on public USPTO records.